vs

Side-by-side financial comparison of Eastern Bankshares, Inc. (EBC) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

Eastern Bankshares, Inc. is the larger business by last-quarter revenue ($295.9M vs $197.9M, roughly 1.5× REPLIGEN CORP). Eastern Bankshares, Inc. runs the higher net margin — 22.1% vs 6.7%, a 15.4% gap on every dollar of revenue. On growth, Eastern Bankshares, Inc. posted the faster year-over-year revenue change (710.6% vs 13.6%). Over the past eight quarters, Eastern Bankshares, Inc.'s revenue compounded faster (38.6% CAGR vs 14.4%).

Eastern Bank is a bank based in Boston, Massachusetts. Before de-mutualizing in 2020, it was the oldest and largest mutual bank in the United States and the largest community bank in Massachusetts.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

EBC vs RGEN — Head-to-Head

Bigger by revenue
EBC
EBC
1.5× larger
EBC
$295.9M
$197.9M
RGEN
Growing faster (revenue YoY)
EBC
EBC
+696.9% gap
EBC
710.6%
13.6%
RGEN
Higher net margin
EBC
EBC
15.4% more per $
EBC
22.1%
6.7%
RGEN
Faster 2-yr revenue CAGR
EBC
EBC
Annualised
EBC
38.6%
14.4%
RGEN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EBC
EBC
RGEN
RGEN
Revenue
$295.9M
$197.9M
Net Profit
$65.3M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
22.1%
6.7%
Revenue YoY
710.6%
13.6%
Net Profit YoY
-34.4%
143.9%
EPS (diluted)
$0.29
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EBC
EBC
RGEN
RGEN
Q1 26
$295.9M
Q4 25
$37.5M
$197.9M
Q3 25
$241.5M
$188.8M
Q2 25
$244.9M
$182.4M
Q1 25
$31.1M
$169.2M
Q4 24
$216.5M
$174.1M
Q3 24
$203.4M
$154.9M
Q2 24
$154.0M
$154.1M
Net Profit
EBC
EBC
RGEN
RGEN
Q1 26
$65.3M
Q4 25
$99.5M
$13.3M
Q3 25
$106.1M
$14.9M
Q2 25
$100.2M
$14.9M
Q1 25
$-217.7M
$5.8M
Q4 24
$60.8M
$-30.3M
Q3 24
$-6.2M
$-654.0K
Q2 24
$26.3M
$3.3M
Gross Margin
EBC
EBC
RGEN
RGEN
Q1 26
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Operating Margin
EBC
EBC
RGEN
RGEN
Q1 26
Q4 25
9.0%
Q3 25
38.9%
8.9%
Q2 25
41.0%
7.6%
Q1 25
-590.9%
3.9%
Q4 24
33.3%
-17.7%
Q3 24
-1.6%
-5.1%
Q2 24
24.7%
1.0%
Net Margin
EBC
EBC
RGEN
RGEN
Q1 26
22.1%
Q4 25
265.6%
6.7%
Q3 25
44.0%
7.9%
Q2 25
40.9%
8.2%
Q1 25
-699.2%
3.4%
Q4 24
28.1%
-17.4%
Q3 24
-3.0%
-0.4%
Q2 24
17.1%
2.2%
EPS (diluted)
EBC
EBC
RGEN
RGEN
Q1 26
$0.29
Q4 25
$0.48
$0.24
Q3 25
$0.53
$0.26
Q2 25
$0.50
$0.26
Q1 25
$-1.08
$0.10
Q4 24
$0.29
$-0.55
Q3 24
$-0.03
$-0.01
Q2 24
$0.16
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EBC
EBC
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$551.7M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$4.3B
$2.1B
Total Assets
$30.6B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EBC
EBC
RGEN
RGEN
Q1 26
$551.7M
Q4 25
$507.6M
$767.6M
Q3 25
$703.4M
$748.7M
Q2 25
$948.3M
$708.9M
Q1 25
$609.0M
$697.2M
Q4 24
$1.9B
$757.4M
Q3 24
$1.7B
$784.0M
Q2 24
$1.4B
$809.1M
Total Debt
EBC
EBC
RGEN
RGEN
Q1 26
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Stockholders' Equity
EBC
EBC
RGEN
RGEN
Q1 26
$4.3B
Q4 25
$4.3B
$2.1B
Q3 25
$3.8B
$2.1B
Q2 25
$3.7B
$2.1B
Q1 25
$3.6B
$2.0B
Q4 24
$3.6B
$2.0B
Q3 24
$3.7B
$2.0B
Q2 24
$3.0B
$2.0B
Total Assets
EBC
EBC
RGEN
RGEN
Q1 26
$30.6B
Q4 25
$30.6B
$2.9B
Q3 25
$25.5B
$2.9B
Q2 25
$25.5B
$2.9B
Q1 25
$25.0B
$2.9B
Q4 24
$25.6B
$2.8B
Q3 24
$25.5B
$2.8B
Q2 24
$21.0B
$2.9B
Debt / Equity
EBC
EBC
RGEN
RGEN
Q1 26
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EBC
EBC
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EBC
EBC
RGEN
RGEN
Q1 26
Q4 25
$432.4M
$25.7M
Q3 25
$157.1M
$48.1M
Q2 25
$123.9M
$28.6M
Q1 25
$47.3M
$15.0M
Q4 24
$283.8M
$39.2M
Q3 24
$108.3M
$49.3M
Q2 24
$54.3M
$42.2M
Free Cash Flow
EBC
EBC
RGEN
RGEN
Q1 26
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
FCF Margin
EBC
EBC
RGEN
RGEN
Q1 26
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Capex Intensity
EBC
EBC
RGEN
RGEN
Q1 26
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Cash Conversion
EBC
EBC
RGEN
RGEN
Q1 26
Q4 25
4.35×
1.93×
Q3 25
1.48×
3.23×
Q2 25
1.24×
1.92×
Q1 25
2.57×
Q4 24
4.67×
Q3 24
Q2 24
2.06×
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons